Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272883 · ClinicalTrials.gov registry record
Molecular and Genetic Studies of Congenital Myopathies
A clinical trial of Myotubular Myopathy and Central Core Disease, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT00272883 is a study of Myotubular Myopathy and Central Core Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 4,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00272883, a study of Myotubular Myopathy and Central Core Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs
Conditions Studied
Study Locations (1)
Massachusetts
- Genetics Division, Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2003-08 |
| Est. Completion | 2050-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272883
The ClinicalTrials.gov registry entry for NCT00272883 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Myotubular Myopathy appearing as the primary indexed condition, and to 0 interventions.
NCT00272883 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00272883 about?
NCT00272883 is a clinical study titled "Molecular and Genetic Studies of Congenital Myopathies". In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type dispropor...
What is the current status of trial NCT00272883?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2003-08. Estimated completion is 2050-01.
What conditions does trial NCT00272883 study?
This clinical trial studies the following conditions: Myotubular Myopathy, Central Core Disease, Centronuclear Myopathy, Congenital Fiber Type Disproportion, Multiminicore Disease.
Who is sponsoring clinical trial NCT00272883?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00272883 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myotubular Myopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.